Natco ₹1,279 Cr Rights Issue to Strengthen Balance Sheet

has approved a ₹1,279.36 crore rights issue, marking a significant capital-raising exercise for the pharmaceutical company. The issue will involve the issuance of 1.71 crore equity shares at ₹750 per share, with the proceeds providing additional financial flexibility for the company. The company will issue 1,70,58,082 new shares at ₹750 each, including a face value of ₹2 and a premium of ₹748 per share. If fully subscribed, the new shares would increase Natco Pharma's equity base by approximately 9.5%. The rights issue is structured as 2 new shares for every 21 shares held, with October 1, 2026 fixed as the record date. The issue is scheduled to open on October 12 and close on October 22, 2026. For existing shareholders, the rights structure allows them to maintain their proportional ownership by subscribing to their entitlement.